Interleukin-13 +1923C/T polymorphism is associated with asthma risk: A meta-analysis

12Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

There are controversies on the association between interleukin-13 (IL-13) +1923C/T polymorphism (rs1295686) and the risk of asthma. We performed this study to assess the association by the method of meta-analysis. A systematic search current to October 16, 2012, was conducted using PubMed, EMBASE, and China National Knowledge Infrastructure (CNKI) and identified ten studies comprising 13698 cases and 38209 controls. The pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. There was a significant association between IL-13 +1923C/T polymorphism and asthma risk in codominant model. When stratified by ethnicity, IL-13 +1923C/T polymorphism remained significantly associated with higher asthma risk in Asians and Caucasians. In the subgroup analysis by study quality, a significantly increased asthma risk was observed in high quality studies. Sensitivity analysis and cumulative analysis further strengthened the validity of the results. No publication bias was found in this meta-analysis. In conclusion, results from this meta-analysis suggested that IL-13 +1923C/T polymorphism was a risk factor of asthma. © 2013 Yongan Liu et al.

Cite

CITATION STYLE

APA

Liu, Y., Liu, T., Nie, W., Lai, G., & Xiu, Q. (2013). Interleukin-13 +1923C/T polymorphism is associated with asthma risk: A meta-analysis. BioMed Research International. https://doi.org/10.1155/2013/394316

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free